Hepatic lipase, high density lipoproteins, and hypertriglyceridemia

American Journal of Pathology

Volumn 178, Issue 4, 2011, Pages 1429-1433

  Chatterjee, Cynthia ^a   Sparks, Daniel L ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; HIGH DENSITY LIPOPROTEIN; INTERMEDIATE DENSITY LIPOPROTEIN; LIVER TRIACYLGLYCEROL LIPASE; PROTEOHEPARAN SULFATE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

BINDING AFFINITY; BLOOD SAMPLING; CIRCULATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME METABOLISM; ENZYME RELEASE; ENZYME SYNTHESIS; GENE MUTATION; HEART DISEASE; HUMAN; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; LIPOLYSIS; LIVER; LIVER CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; RISK FACTOR; SHORT SURVEY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 79953661611     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.12.050     Document Type: Short Survey

References (50)

1. Davignon J, Cohn JS: Triglycerides: a risk factor for coronary heart disease. Atherosclerosis 1996, 124 Suppl:S57-S64
2. Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration, Sarwar N, Sandhu MS, Ricketts SL, Butterworth AS, Di Angelantonio E, Boekholdt SM, Ouwehand W, Watkins H, Samani NJ, Saleheen D, Lawlor D, Reilly MP, Hingorani AD, Talmud PJ, Danesh J: Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet 2010, 375:1634-1639
3. Goldberg IJ: Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 1996, 37:693-707
4. Zambon A, Deeb SS, Pauletto P, Crepaldi G, Brunzell JD: Hepatic lipase: a marker for cardiovascular disease risk and response to therapy. Curr Opin Lipidol 2003, 14:179-189 (Pubitemid 36521189)
5. Baroni MG, Berni A, Romeo S, Arca M, Tesorio T, Sorropago G, Di Mario U, Galton DJ: Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL), and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD. BMC Med Genet 2003, 4:8-15
6. Connelly PW, Hegele RA: Hepatic lipase deficiency. Crit Rev Clin Lab Sci 1998, 35:547-572 (Pubitemid 29034230)
7. McCaskie PA, Cadby G, Hung J, McQuillan BM, Chapman CM, Carter KW, Thompson PL, Palmer LJ, Beilby JP: The C-480T hepatic lipase polymorphism is associated with HDL-C but not with risk of coronary heart disease. Clin Genet 2006, 70:114-121 (Pubitemid 44028096)
8. Hodoglugil U, Williamson DW, Mahley RW: Polymorphisms in the hepatic lipase gene affect plasma HDL-cholesterol levels in a Turkish population. J Lipid Res 2010, 51:422-430
9. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, et al: Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010, 466:707-713
10. Feitosa MF, Myers RH, Pankow JS, Province MA, Borecki IB: LIPC variants in the promoter and intron 1 modify HDL-C levels in a sex-specific fashion. Atherosclerosis 2009, 204:171-177
11. Jansen H, van Berkel TJ, Hülsmann WC: Binding of liver lipase to parenchymal and non-parenchymal rat liver cells. Biochem Biophys Res Commun 1978, 85:148-152 (Pubitemid 9073165)
12. Kuusi T, Nikklä EA, Virtanen I, Kinnunen PK: Localization of the heparin-releasable lipase in situ in the rat liver. Biochem J 1979, 181:245-246 (Pubitemid 9236534)
13. Hahn PF: Abolishment of alimentary lipemia following injection of heparin. Science 1943, 98:19-20
14. Olivecrona T, Bengtsson-Olivecrona G, Ostergaard P, Liu G, Chevreuil O, Hultin M: New aspects on heparin and lipoprotein metabolism. Haemostasis 1993, 23 Suppl 1:150-160 (Pubitemid 23116288)
15. Kuusi T, Ehnholm C, Viikari J, Härkönen R, Vartiainen E, Puska P, Taskinen MR: Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia. J Lipid Res 1989, 30:1117-1126 (Pubitemid 19213252)
16. Patsch J: Influence of lipolysis on chylomicron clearance and HDL cholesterol levels. Eur Heart J 1998, 19 Suppl H:H2-H6
17. Santamarina-Fojo S, Haudenschild C, Amar M: The role of hepatic lipase in lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol 1998, 9:211-219 (Pubitemid 28274350)
18. Jansen H, Verhoeven AJ, Sijbrands EJ: Hepatic lipase: a pro- or anti-atherogenic protein? J Lipid Res 2002, 43:1352-1362
19. Ramsamy TA, Neville TA, Chauhan BM, Aggarwal D, Sparks DL: Apolipoprotein A-I regulates lipid hydrolysis by hepatic lipase. J Biol Chem 2000, 275:33480-33486
20. Ramsamy TA, Boucher J, Brown RJ, Yao Z, Sparks DL: HDL regulates the displacement of hepatic lipase from cell surface proteoglycans and the hydrolysis of VLDL triacylglycerol. J Lipid Res 2003, 44:733-741 (Pubitemid 37279675)
21. Rouhani N, Young E, Chatterjee C, Sparks DL: HDL composition regulates displacement of cell surface-bound hepatic lipase. Lipids 2008, 43:793-804
22. Young EK, Chatterjee C, Sparks DL: HDL-ApoE content regulates the displacement of hepatic lipase from cell surface proteoglycans. Am J Pathol 2009, 175:448-457
23. Sanan DA, Fan J, Bensadoun A, Taylor JM: Hepatic lipase is abundant on both hepatocyte and endothelial cell surfaces in the liver. J Lipid Res 1997, 38:1002-1013 (Pubitemid 27255208)
24. Hill JS, Yang D, Nikazy J, Curtiss LK, Sparrow JT, Wong H: Subdomain chimeras of hepatic lipase and lipoprotein lipase. Localization of heparin and cofactor binding. J Biol Chem 1998, 273:30979-30984 (Pubitemid 28533102)
25. Yu W, Hill JS: Mapping the heparin-binding domain of human hepatic lipase. Biochem Biophys Res Commun 2006, 343:659-665
26. Schoonderwoerd K, Verhoeven AJM, Jansen H: Rat liver contains a limited number of binding sites for hepatic lipase. Biochem J 1994, 302:717-722 (Pubitemid 24289306)
27. Brown RJ, Schultz JR, Ko KW, Hill JS, Ramsamy TA, White AL, Sparks DL, Yao Z: The amino acid sequences of the carboxyl termini of human and mouse hepatic lipase influence cell surface association. J Lipid Res 2003, 44:1306-1314 (Pubitemid 37279611)
28. Kolset SO, Salmivirta M: Cell surface heparan sulfate proteoglycans and lipoprotein metabolism. Cell Mol Life Sci 1999, 56:857-870
29. Tagashira H, Nakahigashi S, Kerakawati R, Motoyashiki T, Morita T: Involvement of Ca2+/calmodulin-dependent protein kinase II in heparin-stimulated release of hepatic lipase activity from rat hepatocytes. Biol Pharm Bull 2005, 28:409-412 (Pubitemid 40879959)
30. 3 for hepatic lipase. Arterioscler Thromb Vasc Biol 1996, 16:755-762
31. Boucher J, Ramsamy TA, Braschi S, Sahoo D, Neville TA, Sparks DL: Apolipoprotein A-II regulates HDL stability and affects hepatic lipase association and activity. J Lipid Res 2004, 45:849-858 (Pubitemid 38552854)
32. Boucher JG, Nguyen T, Sparks DL: Lipoprotein electrostatic properties regulate hepatic lipase association and activity. Biochem Cell Biol 2007, 85:696-708 (Pubitemid 351198417)
33. Blum CB: Dynamics of apolipoprotein E metabolism in humans. J Lipid Res 1982, 23:1308-1316
34. Murdoch SJ, Breckenridge WC: Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL. Atherosclerosis 1995, 118:193-212 (Pubitemid 26013162)
35. Murdoch SJ, Breckenridge WC: Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL. Biochim Biophys Acta 1996, 1303:222-232 (Pubitemid 26349042)
36. Mowri HO, Patsch W, Smith LC, Gotto AM JR, Patsch JR: Different reactivities of high density lipoprotein2 subfractions with hepatic lipase. J Lipid Res 1992, 33:1269-1279
37. Hime NJ, Drew KJ, Hahn C, Barter PJ, Rye KA: Apolipoprotein E enhances hepatic lipase-mediated hydrolysis of reconstituted high-density lipoprotein phospholipid and triacylglycerol in an isoform-dependent manner. Biochemistry 2004, 43:12306-12314 (Pubitemid 39280574)
38. Deeb SS, Zambon A, Carr MC, Ayyobi AF, Brunzell JD: Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, diet. J Lipid Res 2003, 44:1279-1286 (Pubitemid 37279608)
39. Weisgraber KH, Mahley RW: Apoprotein (E - A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction. J Biol Chem 1978, 253:6281-6288
40. Jain MK, Berg OG: The kinetics of interfacial catalysis by phospholipase A2 and regulation of interfacial activation: hopping versus scooting. Biochim Biophys Acta 1989, 1002:127-156 (Pubitemid 19090938)
41. Couillard C, Bergeron N, Prud'homme D, Bergeron J, Tremblay A, Bouchard C, Mauriège P, Després JP: Gender difference in postprandial lipemia: importance of visceral adipose tissue accumulation. Arterioscler Thromb Vasc Biol 1999, 19:2448-2455 (Pubitemid 29477847)
42. Patsch Jr, Karlin JB, Scott LW, Smith LC, Gotto AM Jr: Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci USA 1983, 80:1449-1453 (Pubitemid 13085376)
43. Chatterjee C, Young EK, Pussegoda KA, Twomey EE, Pandey NR, Sparks DL: Hepatic high-density lipoprotein secretion regulates the mobilization of cell-surface hepatic lipase. Biochemistry 2009, 48:5994-6001
44. Pandey NR, Renwick J, Misquith A, Sokoll K, Sparks DL: Linoleic acid-enriched phospholipids act through peroxisome proliferator-activated receptors alpha to stimulate hepatic apolipoprotein A-I secretion. Biochemistry 2008, 47:1579-1587 (Pubitemid 351231208)
45. Pandey NR, Renwick J, Rabaa S, Misquith A, Kouri L, Twomey E, Sparks DL: An induction in hepatic HDL secretion associated with reduced ATPase expression. Am J Pathol 2009, 175:1777-1787
46. Ben-Zeev O, Doolittle MH: Maturation of hepatic lipase. Formation of functional enzyme in the endoplasmic reticulum is the rate-limiting step in its secretion. J Biol Chem 2004, 279:6171-6181 (Pubitemid 38220650)
47. Doolittle MH, Ehrhardt N, Peterfy M: Lipase maturation factor 1: structure and role in lipase folding and assembly. Curr Opin Lipidol 2010, 21:198-203
48. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB: Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 1986, 256:2835-2838 (Pubitemid 17178361)
49. Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart JC: Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 1998, 98:2088-2093 (Pubitemid 28512236)
50. Kamanna VS, Kashyap ML: Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents? Am J Cardiol 2007, 100:S53-S61